Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (12 years) with haemophilia A or B with inhibitors
- Resource Type
- Source
- Haemophilia, Vol. 28, no. 4, p. 548-556 (2022)
- Subject
paediatric Cross-Over Studies PERSEPT haemophilia Hemorrhage Hematology General Medicine Factor VIIa Hemophilia A Recombinant Proteins inhibitors Humans recombinant FVIIa Child eptacog beta Genetics (clinical) - Language
- ISSN
- 1365-2516